InMed Pharmaceuticals Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q3 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
InMed Pharmaceuticals Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q3 2020 to Q4 2023.
  • InMed Pharmaceuticals Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending December 31, 2023 was $1.3M, a 113% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $1.3M +$690K +113% Dec 31, 2023 10-Q 2024-02-13
Q3 2023 $298K -$241K -44.7% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $394K Jun 30, 2023 10-K 2023-09-29
Q1 2023 $501K Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $610K Dec 31, 2022 10-Q 2023-02-17
Q3 2022 $539K Sep 30, 2022 10-Q 2022-11-14
Q2 2021 $312K Jun 30, 2021 10-K 2021-09-24
Q1 2021 $589K Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $582K Dec 31, 2020 10-Q 2021-02-11
Q3 2020 $363K Sep 30, 2020 10-Q 2020-12-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.